Published in TB and Outbreaks Week, October 5th, 2004
According to a study from Canada, "A bispecific monoclonal antibody (bsMAb) that detects Bordetella pertussis, the causative agent of whooping cough, and horseradish peroxidase (HRPO) has been developed by use of the quadroma technology."
"The quadroma was theoretically expected to produce up to 10 different molecular species of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week